Latest News for: adoa

Edit

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)

Pharmiweb 11 Feb 2026
–Dose-escalating study will evaluate the safety, tolerability and exposure of STK-002 in people with ADOA... ADOA is a rare genetic disease that causes progressive and irreversible vision loss in both eyes starting in the first decade of life.
Edit

ADOA Cooling Centers Hosted 59% More Visits in Summer 2025 (Arizona Department of Administration)

Public Technologies 10 Nov 2025
On May 5, ADOA opened a unit at 1601 W ... He has observed firsthand how the ADOA Cooltainers have helped people from all walks of life when they need heat relief ... ADOA used several local small business ...
  • 1
×